Which one of the following provides hemodynamic stability and prolongs survival in congestive hea failure?
**Core Concept**
The management of congestive heart failure (CHF) involves pharmacological interventions that improve hemodynamics, reduce morbidity, and prolong survival. This question assesses the student's understanding of the pathophysiology and treatment of CHF, specifically the role of vasodilators and inotropes.
**Why the Correct Answer is Right**
Angiotensin-converting enzyme (ACE) inhibitors, such as enalapril, provide hemodynamic stability and prolong survival in congestive heart failure by:
* Reducing afterload through vasodilation, which decreases the workload on the heart and improves cardiac output
* Inhibiting the renin-angiotensin-aldosterone system (RAAS), which decreases aldosterone-mediated fluid retention and sodium reabsorption
* Slowing the progression of left ventricular dysfunction through neurohormonal modulation
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is likely a distractor, as there is no well-known medication that provides hemodynamic stability and prolongs survival in CHF by the described mechanism.
* **Option B:** This option might be a distractor, as digoxin is primarily used to increase the force of contraction in heart failure, but it does not provide long-term hemodynamic stability or improve survival.
* **Option C:** This option might be a distractor, as beta-blockers are used in CHF to reduce sympathetic tone and improve survival, but they do not provide immediate hemodynamic stability.
**Clinical Pearl / High-Yield Fact**
ACE inhibitors should be considered first-line therapy in patients with CHF, as they have been shown to improve survival and reduce hospitalizations.
**Correct Answer:** C.